Abits
ABTS
Bakkt Holdings
BKKT
Riot Platforms
RIOT
Canaan
CAN
CATHEDRA BITCOIN INC
CBTTF
US Stock MarketDetailed Quotes
AGIO Agios Pharmaceuticals
- 38.965
- +0.795+2.08%
Close Dec 13 16:00 ET
- 38.960
- -0.005-0.01%
Post 20:01 ET
2.22BMarket Cap3.34P/E (TTM)
39.480High37.200Low1.35MVolume38.080Open38.170Pre Close52.14MTurnover2.67%Turnover RatioLossP/E (Static)57.03MShares62.58052wk High1.37P/B1.97BFloat Cap20.96052wk Low--Dividend TTM50.52MShs Float138.850Historical High--Div YieldTTM5.97%Amplitude15.770Historical Low38.591Avg Price1Lot Size
About Agios Pharmaceuticals Company
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
Company Profile
SymbolAGIO
Company NameAgios Pharmaceuticals
Listing DateJul 24, 2013
Issue Price18.00
Founded2007
CEOMr. Brian Goff
MarketNASDAQ
Employees386
Fiscal Year Ends12-31
Address88 Sidney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139-4169
Phone1-617-649-8600
Websitehttp://www.agios.com
Company Executives
- Name
- Position
- Salary
- Brian Goff
- Chief Executive Officer and Director
- 3.42M
- Dr. Sarah Gheuens, M.D.,PhD
- Chief Medical Officer and Head of Research and Development
- 2.87M
- Tsveta Milanova
- Chief Commercial Officer
- 3.73M
- James William Burns
- Chief Legal Officer
- 1.93M
- Cecilia Jones
- Chief Financial Officer
- 1.21M
- T. J. Washburn
- Principal Accounting Officer, Vice President and Controller
- --
- Dr. Jacqualyn A. Fouse, PhD
- Chairman of the Board
- 447.25K
- Dr. Maykin Ho, PhD
- Independent Director
- 424.75K
- Dr. David P. Schenkein, M.D.
- Independent Director
- 417.25K
- Catherine Owen
- Independent Director
- 659.94K
- Kaye Foster
- Lead Independent Director
- 440.95K
- Dr. Rahul D. Ballal, PhD
- Independent Director
- 427.25K
- Dr. David T. Scadden, M.D.
- Independent Director
- 429.75K
- Jeffrey D. Capello
- Independent Director
- 663.68K
- Cynthia Smith
- Independent Director
- 419.91K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.